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Primary resistance to pathogens is reliant on both
basal and inducible immune defenses. To date,
research has focused upon inducible innate immune
responses. In contrast to resistance via cytokine
induction, basal defense mechanisms are less
evident. Here we showed that the antiviral protein
kinase R (PKR) inhibited the key actin-modifying
protein gelsolin to regulate actin dynamics and
control cytoskeletal cellular functions under homeo-
static conditions. Through this mechanism, PKR
controlled fundamental innate immune, actin-depen-
dent processes that included membrane ruffling and
particle engulfment. Accordingly, PKR counteracted
viral entry into the cell. These findings identify a layer
of host resistance, showing that the regulation of
actin-modifying proteins during the innate immune
response bolsters first-line defense against intracel-
lular pathogens and has a sustained effect on virus
production. Moreover, these data provide proof of
principle for a concept in which the cell cytoskeleton
could be targeted to elicit broad antiviral protection.
INTRODUCTION
In order to mount a sustainable infection, a pathogen must over-
come the host’s defense mechanisms. This initial resistance to
infection is regulated by the innate immune system, which
consists of nonspecific basal and inducible resistance compo-
nents. Through innate immunity the host first resists infection,
then upon breach of the defenses of the cell, rapidly responds
to induce resistance factors that restrain the pathogen and elicit
specific humoral and cell-mediated responses. Our under-
standing of the inducible innate immune response has been
greatly advanced by elucidation of cell signaling pathwaysmedi-
ated by the cytoplasmic helicases retinoic acid-inducible gene I
(RIG-I) and MDA5 and by the Toll-like and NOD-like receptors.
Activation of these pathogen-recognition receptors potently
induces cytokines and inherent inflammatory processes to acti-vate immune cells, thereby curbing infection. There has not,
however, been an equivalent advance in our understanding of
basal innate immune-resistance processes, because these
cellular resistance factors are not distinguished during an infec-
tion by conspicuous induction. Hence, the specific factors that
instigate this resistance are largely unknown and there is a lack
of detail of the molecular mechanisms that enforce basal resis-
tance to pathogens.
A major component of this basal resistance is structural
defense, established by mechanical features of the cell. The
central component of this is the actin cytoskeleton of the cell.
Not only is the cytoskeleton critical for reorganization of the
cell membrane during pathogen entry to the cell, but it also orga-
nizes host defenses. The actin cytoskeleton arranges pathogen-
recognition receptors and recruits cell-signaling intermediates,
underpins cellular migration and vesicle movements, and medi-
ates membrane movements in processes such as endocytosis
by membrane ruffling and phagocytosis. More than 100 actin-
binding proteins have been identified that regulate nucleation
and polymerization of monomeric actin to form fibers and
higher-order actin structures, or alternatively, sever actin fibers
to remodel the cytoskeleton (dos Remedios et al., 2003).
Processes that regulate the activity of actin-binding proteins,
with resulting consequence to the cytoskeleton, are poorly char-
acterized. Hence, a greater insight into actin dynamics during
host-pathogen interaction is needed. Here we identify that the
innate immune protein kinase R (PKR) has a previously unrecog-
nized role as an actin modifier through control of the actin-
binding protein gelsolin (GSN).
GSN is a constitutively expressed protein that resides in
a closed conformation until activation, whereupon the protein
binds to and severs large actin filaments, altering cell shape
and accelerating retraction of filopodia during motility (Lu et al.,
1997; Safiejko-Mroczka and Bell, 2001). GSN also has the ability
to cap the barbed ends of filaments and trigger actin nucleation,
allowing the formation of lamellipodia and phagocytic cups
(Arora et al., 2005; Groves et al., 2008; Mazur et al., 2010). In
addition, GSN has been implicated in the crosstalk of signaling
events from the membrane to the cytoskeleton, triggered by
phospholipid binding (Lin et al., 1997; Sun et al., 1997). Through
these functions, GSN controls cell morphology, migration, inva-
sion, and movement of the cell membrane. Aberrant expression
of GSN has been correlated with a variety of pathologies (AidinisImmunity 36, 795–806, May 25, 2012 ª2012 Elsevier Inc. 795
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GSN in mice generates a number of nonlethal physiological
and developmental defects (Chellaiah et al., 2000; Crowley
et al., 2000; Furukawa et al., 1997; Witke et al., 1995). Interest-
ingly, the GSN-deleted mouse has altered inflammatory
processes, most conspicuously via altered platelet and neutro-
phil function (Witke et al., 1995). The activity of GSN has
previously been shown to be regulated by calcium influx ormodi-
fications triggered by protein or lipid interactions with molecules
such as phosphatidylinositol-4,5-biphosphate (PtdIns(4,5)P2). A
role for GSN in the innate immune response has not been inves-
tigated. Intriguingly, another member of the GSN family of actin-
binding proteins, Flightless 1 (FLI1), has been involved in the
innate immune responses via Toll-like receptor (TLR) signaling.
FLI1 contains a leucine-rich repeat domain, in addition to the
six GSN-like domains, which allows this protein to bind to the
TLR adaptor molecule MyD88 (Wang et al., 2006). This function
of FLI1 manifests a link between innate immune cell signaling
and GSN-like proteins that remodel the actin cytoskeleton.
PKR is an effector molecule of the innate immune system that
responds to cellular stress, typically that associated with viral
infection. The protein has been established to function in two
principal manners: as an inhibitor of protein translation, via
control of the eukaryotic initiation factor 2a, and as a cell
signaling molecule, by less-well-determined processes.
Although not previously linked to cellular morphology, we
showed that cells from the PKR-deleted mouse have an altered
actin cytoskeleton. Moreover, PKR-deficient cells were altered in
actin-dependent processes such as morphology and structural
dynamics compared towild-type (WT) cells. Fittingly, we demon-
strated that PKR directly inhibited GSN. Opposing the previously
demonstrated dependence for activation by viral RNA, the effect
of PKR upon GSN occurred at homeostatic condition, was rein-
forced by interferon (IFN), which further induced the constitu-
tively expressed PKR, andwas lost upon activation of the kinase.
Hence, PKR alters the cell cytoskeleton to instigate basal resis-
tance. Consistent with this, PKR was shown to suppress virus
entry to the cell. This observed regulation of actin dynamics by
an innate immune protein provides insight into molecular mech-
anisms of cellular resistance to intracellular pathogens.
RESULTS
Innate Immune Regulation of the Cytoskeleton
In the course of culturing murine embryonic fibroblasts (MEFs)
ablated for the innate immune protein PKR (encoded by Eif2ak2),
we observed differences in features of the cell morphology and
motility of WT compared to PKR-deficient cells (see below).
We attributed this to fundamental changes in the cell cytoskel-
eton, because Eif2ak2/ cells were found to have altered actin
filaments (Figure 1A). Primary WT and PKR-deficient MEFs were
examined for differences in actin stress fiber formation after
growth in reduced serum. Actin fibers were visualized with Alexa
488-labeled phalloidin and quantitated with the Imaris software.
Figure 1A shows that cells ablated for PKR were devoid of most
large actin protofilaments, had a decrease in the total number of
filaments, and had shorter average filament length and
a decreased total amount of filamentous actin when compared
to WT MEFs. Given the context of the role of PKR in immunity,796 Immunity 36, 795–806, May 25, 2012 ª2012 Elsevier Inc.we considered this observation likely to be of significance in
infection.
The actin cytoskeleton is essential to many fundamental cell
processes, including immune processes such as membrane
ruffling. Membrane ruffling is an important endocytic process
in fibroblasts that enables the cell to sample the extracellular
environment. We compared the ability of WT or PKR-deficient
MEFs to form bilateral membrane ruffles in response to serum,
as sections of curvedmembrane folding onto itself, as described
previously (Hedberg et al., 1993; Nobile et al., 2010; Sun et al.,
1995). PKR-deficient MEFs display increased membrane ruffling
in response to serum treatment (Figure 1B). Because membrane
ruffling is inherently linked to particle engulfment, we investi-
gated whether PKR altered endocytic uptake. To this end, cells
were incubated with FITC-conjugated dextran molecules and
then imaged. As Figure 1C shows, PKR-deficient fibroblasts
exhibit increased endocytic uptake of fluorescein isothiocyanate
(FITC)-dextran particles, consistent with their increased mem-
brane ruffling. Because no mechanism has been recognized
that would account for this, we sought to determine the relevant
regulatory processes.
PKR Interacts with the Actin-Binding Protein GSN
To identify proteins that interact with PKR, we performed an
immunoprecipitation of PKR from MEFs and identified coimmu-
noprecipitated proteins by mass spectrometry. The actin-
binding protein GSN was identified through this procedure
(Figure S1A available online). The association between PKR
and GSN was further characterized by Fo¨rster’s resonance
energy transfer (FRET) analysis of fluorescent-tagged protein
constructs. GSN was expressed as a cyan fluorescent protein
(CFP) fusion, whereas PKR was fused to the full-length Venus
fluorescent protein and expressed in HEK293T cells. The
observed FRET efficiency demonstrates that a high proportion
of the two proteins associate in the cell (Figure 2A). As a compar-
ison, FRET efficiencies were calculated between GSN-CFP and
actin. This demonstrates that the proportion of GSN associated
with PKR approaches the amount of GSN bound to actin fila-
ments in the cell. The FRET pairing discerned that the associa-
tion between GSN and PKR was uneven throughout the cell,
being highest at regions close to the edge of a cell, though not
in the leading edge, an area where functional GSN is known to
concentrate during migration (Figures 2A and S1B).
To further probe this interaction, we utilized a bimolecule
fluorescence approach. In this method, each protein partner
is expressed as a fusion construct with separate halves of
the Venus fluorophore (as shown in Figure S2). Proteins that
interact allow the two halves of the fluorophore to associate,
thereby producing a fluorescent signal. Toward this, GSN and
WT, or a series of truncated, PKR constructs were fused to
either half of Venus then transfected into HEK293T cells. This
demonstrated that GSN interacts with the kinase domain of
PKR within the region termed the N-lobe (Figures 2B and
S1C). The N-lobe has previously been demonstrated to form
the interaction interface between each monomer in the active
dimeric enzyme (Dey et al., 2005). Consequently, we measured
the interaction between GSN and dimeric PKR by measuring
FRET between GSN-CFP and PKR monomers fused separately
with each half of the split Venus. Because no FRET was
Figure 1. MEFs Ablated for PKR Exhibit
Altered Morphology
(A) A quantitation of the state of actin in primary
WT and PKR-deficient (null) MEFs. Graphs repre-
sent the accumulated data of 50 images for total
number of actin filaments, total amount of fila-
mentous actin, and average filament length as
quantified by volume rendering in the Imaris soft-
ware. Example images of primary MEFs are dis-
played below the graphs as a flattened maximum
intensity projection from z stacks for the entire cell.
(B) Images of WT and PKR-deficient (null) primary
MEFs transfected with mRFP-actin. Cells were
fixed, labeled, and imaged for the presence of
membrane ruffles (indicated by arrows). Ruffles
were visualized in 3D in Imaris as curves of
membrane rising off the surface. The lower panel
contains magnified projected 2D images for
identification of what is considered a ‘‘ruffle’’ and
is quantified in the graph on right. Further visuali-
zation of ruffles can be seen in Movies S1 and S2.
(C) WT and PKR-deficient (null) primary MEFs
treated with a 3 kDa FITC-dextran molecule. The
amount of dextran internalized (mean fluores-
cence), through reference to a CellMask plasma
membrane stain (removed for image clarity) was
quantified with Image J (graphed on the right).
Error is displayed as mean ± SEM.
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GSN interacts with monomeric, inactive PKR (Figure S1B).
Notably, a mutated kinase-dead PKR, in which dimer formation
is altered by a point mutation (K296R), bound GSN (Figure 2C).
In light of this, we tested the effects of activation stimuli for PKR
on the protein association. HeLa cells were treated with the
double-stranded (ds) RNA mimetic, polyinosinic:polycytidylic
acid (poly(I:C)). Endogenous PKR was immunoprecipitatedImmunity 36, 795–and coimmunoprecipitation of endoge-
nous GSN was tested by immunoblot.
Consistent with the preceding data,
PKR and GSN associate under homeo-
static conditions but dissociate upon
activation of PKR with poly(I:C) (Figures
2D and S1D). Fluorescence lifetime
imaging (FLIM)-FRET was used to visu-
alize this temporal protein association
between PKR-Venus and GSN-CFP.
Basal FRET efficiency was compared
to cells after activation of PKR with
poly(I:C) or by infection with the herpes
simplex virus type 1 (HSV-1), which has
been demonstrated previously to acti-
vate PKR (Leib et al., 2000). The lifetime
of the GSN interaction with PKR is
shown, in Figure 2E, as a heatmap within
the cell. FLIM-FRET analysis calculated
the efficiency of the interaction averaged
across whole cells between PKR and
GSN to be 11%. This interaction
decreased to 3% or 4% upon treatmentwith HSV-1 or poly(I:C), respectively (Figures 2F, S1E, and
S1F). To ensure that the poly(I:C)-mediated decrease in FRET
was a specific result of the kinase activation of PKR, the
FLIM-FRET was repeated with the kinase-dead mutant
K296R PKR. Consistent with the preceding data, poly(I:C) treat-
ment did not decrease FRET between GSN and K296R PKR.
Appropriately, there was no poly(I:C)-induced change in the
association of GSN with its substrate (Figure 2G). Together,806, May 25, 2012 ª2012 Elsevier Inc. 797
Figure 2. PKR Binds GSN at Homeostatic Conditions
(A) An intensity merged image of CFP-GSN and Venus-PKR transfected HEK293T cells (left) and a heatmap of FRET efficiency, above a 10% cutoff (center), as
measured by Acceptor-photobleaching FRET. In the right panel is a graph of FLIM-FRET efficiencies calculated bymeasuring the shift in donor lifetimewith the LI-
FLIM software of CFP-GSN after the addition of a FRET acceptor with either PKR or actin-Venus fusions, or Venus alone as a control for nonspecific fluorophore
interaction. Additional controls are shown in Figure S1B.
(B) Fluorescence in HEK293T cells formed by interaction of split Venus between GSN fused to V1 and full-length protein (PKR) or constructs lacking the RNA-
binding (DRBD) and linker (DLink) domains, or the N- and C-lobes of the kinase domain (DN-lobe and DC-lobe, respectively) of PKR fused to V2. Venus fluo-
rescence in cells was normalized to the expression of the various PKR constructs, by detecting the V2 peptide with a GFP antibody (shown on left). A quantitation
of approximately 50 images per transfection is graphed on the right.
(C) Fluorescence in HEK293T cells formed by interaction of Venus split betweenGSN fused to V2 and eitherWT or kinase-dead PKR (K296) fused to V1. Cell nuclei
were detected with Hoechst 3342 stain in (B) and (C).
(D) An immunoblot of proteins immunoprecipitated with amonoclonal antibody to PKR (70/10) fromHeLa cell extracts. Cells were untreated (Cont) or treated with
poly(I:C) (10 mg/ml) to activate PKR. Proteins were probed with a mousemonoclonal antibody against GSN and quantified (right) relative to the level of GSN in the
whole cell lysate (input).
(E) FLIM time-scaled average tp-lifetime images (2.2–3.2 ns) in HEK293T cells with GSN-CFP (control) and GSN-CFP and PKR-Venus untreated (GSN-PKR) and
infected with HSV-1, or transfected with poly(I:C). Shorter donor lifetimes indicate the presence of FRET as detected by FLIM.
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PKR Inhibits GSN, Altering Actin Dynamicsthis analysis shows that GSN and PKR associate at homeo-
stasis but disassociate upon activation of PKR.
Activity of GSN Is Inhibited by the Association with PKR
Because GSN is known to be phosphorylated by other kinases
(De Corte et al., 1997), we tested whether GSN was a substrate
for PKR in an in vitro kinase assay, as described previously (Sa-
dler et al., 2009). Toward this, glutathione sepharose transferase
(GST) GSN constructs were generated, as shown in Figure S2,
for kinase assays. However, no phosphorylation of the GSN
peptides could be detected (Figures S3A–S3C).
Because our earlier investigations revealed a morphological
defect in Eif2ak2/ MEFs, notwithstanding the lack of measur-
able phosphorylation of GSN, we investigated whether the asso-
ciation with PKR affected the function of GSN. Toward this, an
in vitro actin polymerization assay was performed as described
elsewhere (Ferjani et al., 2006). In brief, rhodamine-labeled
nonnucleated actinmonomers were incubated with recombinant
functional GSN protein (GSN1-6) or, as a control, a truncated
nonfunctional GSN peptide (GSN3-4). In this assay, polymeriza-
tion of actin monomers induces a fluorescent signal. Figure 3A
shows that GSN1-6 reduced the fluorescent signal in accord
with its actin-severing ability (see also Figure S3D). Appropri-
ately, the inactive peptide GSN3-4 had no effect. Importantly,
the actin-severing activity of GSN1-6 was perturbed by WT re-
combinant PKR. In keeping with the lack of observed phosphor-
ylation of GSN, the kinase-dead variant of PKR (K296R) similarly
inhibited GSN-severing activity (Figure 3A).
To investigate actin dynamics in live cells, fibroblast cell lines
were transfected with actin-red fluorescent protein (RFP) and
actin filament formation was visualized by fluorescence recovery
after photobleaching (FRAP). Fluorescence recovery is depen-
dent upon actin polymerization, which has been established to
be strongly dependent on GSN activity (Campbell and Knight,
2007; Halavatyi et al., 2009). Large actin filaments were photo-
bleached and the fluorescence recovery profiles of filaments
were measured. Consistent with PKR-dependent inhibition of
GSN, MEFs that were ablated for PKR show amarkedly reduced
rate of fluorescence recovery compared toWTMEFs (Figures 3B
and S3E). To confirm that this effect was mediated by PKR, the
human PKR genetic locus was reintroduced into PKR-deficient
MEFs (coded Bac7) and compared to cells containing the locus
but not expressing PKR (Bac10) (Figure S3F). The restoration of
PKR expression reinstated the recovery of actin filaments
(Figures 3B and S3F; Movies S3 and S4).
GSN-dependent severing of actin alters the ratio of filamen-
tous (F) to monomeric (G) actin. Therefore, the proportion of F-
to G-actin was quantitated in WT and PKR-deficient MEFs by
labeling with Alexa 488 phalloidin and tetramethyl rhodamine
isothiocyanate (TRITC)-deoxyribonuclease-I, respectively. In
keeping with the inhibition of GSN activity by PKR shown
in vitro, PKR-deficient cell lines had an increased proportion of
G-actin compared to WT cells (Figure 3C). This was despite
a constant level of GSN expression between cell types (Fig-(F) A quantitation of the FLIM-FRET efficiencies from (E) representing FRET effic
(G) A quantitation of the FLIM-FRET efficiencies betweenmCherry alone as a contr
each tagged with EGFP. Cells are treated (+) with the PKR activator poly(I:C) to
Error is displayed as mean ± SEM.ure S3G). As performed previously, restoration of PKR expres-
sion in MEFs ablated for murine PKR (Bac7) restored the
amounts of F-actin compared to the isogenic cells in which the
introduced construct was not expressed (Bac10) (Figure 3C).
To confirm that the effect of PKR on the actin cytoskeleton
was dependent upon GSN, amounts of GSN were reduced in
fibroblasts by RNA interference. WT and PKR-deficient fibro-
blasts were treated with control (lamin A/C) or small interfering
RNAs (siRNAs) targeting GSN and actin filaments were visual-
ized as described previously. Figure 3D shows that reduction
of GSN rescues the formation of actin filaments in the PKR-defi-
cient cells.
The combined data indicate that the presence of PKR alters
the dynamics of actin within a cell by inhibiting GSN-mediated
severing of actin filaments. This activity of PKR is apparently
independent of its kinase activity.
GSN Is Inhibited by Steric Hindrance
To explain these findings, we propose that the effect of PKR
upon actin dynamics is mediated via steric inhibition of the
activity of GSN. At homeostasis, GSN forms a spatial arrange-
ment in which the actin-binding domains are inaccessible. Acti-
vation of GSN instigates a conformational change to expose its
actin-binding domain. We propose that PKR binding prevents
this conformational change or otherwise obscures the critical
actin-binding domains of GSN. To test this, we measured the
proportion of GSN that was bound to actin in the presence or
absence of PKR by FLIM-FRET. Figure 4A shows that titration
of PKR into Eif2ak2/ cells led to a progressive decrease in
the proportion of GSN that associates with actin, confirming
that binding of PKR prevents the association of GSN with its
substrate.
This was further explored by mutation of GSN. Structural
studies show that an a helix encoded by the C-terminal residues
of GSN contacts an a helix within the second domain of the
molecule, thereby establishing a structural constraint on GSN
activity (Burtnick et al., 1997). Deletion of 19 C-terminal residues
of GSN (coded GSNCT), including an aspartic acid trimer that
has been proposed to mediate the inhibitory intradomain inter-
action, reduced the association with PKR (Figure 4B). Hence,
these data suggest that PKR preferentially associates with the
inactive GSN molecule or directly interacts with the C-terminal
19 amino acids of GSN. However, because PKR retains some
association with this mutant GSN as well as a GSN peptide
that lacked the C-terminal half of the molecule, residues within
GSN N-terminal half are sufficient for the interaction
(Figure S3H).
Our findings predict that increased amounts of PKR will
increase cellular F-actin. In keeping with this, treatment of
MEFs with type I IFN, which induces PKR, increased the number
of filaments (Figures 4C and S4). Notably, this effect occurred
only in the PKR WT cells, demonstrating a strong dependence
on PKR for the IFN-dependent increase in actin filaments. A
second prediction from our preceding experiments is thatiency averaged across the whole cell with the LI-FLIM software.
ol andmCherry tagged toGSNwithWT or kinase-dead (K296R) PKR and actin,
test the dependency of the kinase activity of PKR in the interaction with GSN.
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Figure 3. GSN Activity Is Inhibited by PKR
(A) Actin polymerization, measured by fluorescence, was studied in vitro with recombinant rhodamine-labeled actin in the presence or absence of WT (PKR) or
kinase-dead PKR (K296R) and GSN peptides encompassing all GSN-like domains, or domains 3–4 of GSN (labeled as GSN and G3-4, respectively). Actin
polymerization was quantified as the mean fluorescence intensity for a minimum of 15 fields of view per sample. A representative image of fluorescent actin
fragments on glass slides is presented below the graph.
(B) A comparison of actin polymerization rates visualized by FRAP,withmRFP-actin inWT and PKR-deficientMEFs. The graph displays normalized, accumulated
data for multiple experiments with a minimum of 35 filaments per cell type, per time point. Points represent mean fluorescence intensity for all filaments; curve
indicates one-phase exponential association regressions. This experiment was repeated with PKR-deficient Bac10 cells and the isogenic PKR-reconstituted
Bac7 cells.
(C) A quantitation of the ratio of F- to G-actin in various WT and PKR-deficient MEFs. The graph displayed is an accumulation of three independent experiments
with an example image for each sample shown below the graph.
(D) A quantitation of the number of Alexa 647-Phalloidin-labeled actin filaments in WT or PKR-deficient MEFs treated with siRNAs against GSN (siGSN) or as
a control lamin A/C (siLam1). Representative images shown below the graph are flattenedmaximum intensity projections of 3D deconvolved z stacks captured on
the Deltavision. Constant exposure and contrast settings are used to emphasize differences in filamentous actin staining.
Error is displayed as mean ± SEM.
Immunity
PKR Inhibits GSN, Altering Actin Dynamics
800 Immunity 36, 795–806, May 25, 2012 ª2012 Elsevier Inc.
Figure 4. Regulation of GSN by PKR
(A) FLIM-FRET between GSN-CFP and YFP-actin was used to quantitate the
association of GSN with actin in PKR-deficient fibroblasts transfected with
increasing amounts of a PKR expression construct (at amounts shown).
(B) FLIM-FRET efficiencies observed for the interaction between PKR-Venus
and eitherWT or a 19 amino acid C-terminal truncatedmutant (codedGSN and
GSNCT, respectively) of GSN-CFP.
(C) Quantified actin filament data, as per Figure 1A, with primary WT or PKR-
deficient MEFs treatedwithmurine IFN-a1 (1000U/ml) and poly(I:C) (10 mg/ml).
Immunity
PKR Inhibits GSN, Altering Actin Dynamicsactivation of PKR should mitigate this PKR-dependent inhibition
of GSN. Accordingly, treatment of MEFs with the PKR activator
poly(I:C) reduced the actin filaments. Hence, PKR affects actin
structure in cells and this effect is dependent upon both the level
and activation state of the kinase, as well as the state of GSN.
GSN Controls Virus Uptake, Entry, and Production
Taken together, the initial observed differences in endocytic
processes and the preceding results proffer a rationale for the
control of GSN by PKR, namely to bolster innate resistance to
intracellular pathogens by decreasing uptake by the cell. To
test this, we treated fibroblasts with either control or siRNA-tar-
geting GSN, then infected these knockdown cells with human
rhinovirus-16 (HRV-16). RNA interference reduced GSN protein
amounts by approximately 60% (Figures S5A and S5B). Rhino-
virus entry was quantified by probing for the viral VP2 major
capsid protein by immunofluorescence. This reduction in GSN
was paralleled by a 2-fold reduction in HRV-16 entry into cells
(Figure 5A). To ensure that this effect is not limited to the HRV-
16, we tested the sensitivity to a second pathogen, HSV-1. WT
MEFs were treated with siRNAs as before and then infected
with a green fluorescent protein (GFP)-tagged HSV-1 (eGFP-
HSV-1). Virus entry to the cell was quantified by demarcating
the cell boundary and then measuring GFP fluorescence inside
the cell. Figure 5B shows a reduction in the uptake of HSV-1
in the cells treated with an siRNA-targeting GSN. To measure
the effect of GSN on virus production and cell survival, the
permissive A549 cells were treated with siRNA prior to infection
with HRV-16 and HSV-1, cell survival was monitored, and
progeny virus was quantified by titrating supernatants 24 hr
postinfection onto L929 cells. In keeping with a role for GSN in
promoting virus infection, knockdown of GSN reduced HSV-1
production (Figures 5C and S5B–S5D). In addition, HRV-16
produced from GSN knockdown cells exhibited less virus-
induced death (Figures 5D, S5D, and S5E).
The observed control of GSN by PKR argues that PKR should
similarly inhibit virus entry. To directly test this possibility, we in-
fected WT, PKR-deficient, and MEFs expressing catalytically
inactive murine PKR, K271R, equivalent to the K296 of human
PKR, with eGFP-HSV-1. PKR-deficient fibroblasts exhibited
greater than 2-fold higher virus uptake compared to WT cells.
Moreover, the catalytically inactive PKR provided at least
comparable protection to the WT protein, consistent with the
effects of PKR being independent of direct phosphorylation of
GSN and supporting the notion that inactive PKR regulates
GSN (Figures 5E and S5F).
To examine the significance of GSN in an in vivo infection, we
utilized a murine lung infection model (DuPage et al., 2009).
C57BL6/J mice were initially treated by intranasal inhalation of
lentivirus expressing either control nontargeting short hairpin
(sh)RNA or a pool of four shRNAs targeting GSN to reduce
GSN levels in the lung tissue. After 3 days, mice were then simi-
larly infected with a recombinant LacZ adenovirus. After a further
4 days, the lungs were harvested and assessed for the levels of
GSN and virus-specific b-galactosidase. ImmunocytochemistryOne of three experiments is representedwith aminimumof 50 cells per sample
counted. Error is displayed as mean ± SEM.
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Figure 5. Control of GSN by PKR Affects Virus Entry and Production
(A) Immunofluorescence performed on HRV-16-infected (MOI = 100) MEFs treated with siRNA against GSN (siGSN) or as a control lamin A/C (siLAM1) (left).
Levels of HRV-16within the cell are quantitated 1 hr after infection by immunocytochemical detection of the HRV-16 VP2 capsid protein (green). Actin was labeled
with Alexa 647-phalloidin (magenta). The graph (on right) represents the average HRV-16 uptake in three experiments. Images are individual confocal planes from
‘‘tile-scanning’’ (n > 50) with the Zeiss LSM780 confocal.
(B) A quantitation of virus uptake, measured as GFP fluorescence intensity, for MEFs infected with eGFP-HSV-1 (MOI = 100) and treated with siRNAs as per (A).
(C) A quantitation of virus production, assayed by secondary infection of L929 cells, from a primary infection of A549 cells treated with siRNAs as per (A) with
eGFP-HSV-1 (MOI = 1). The L929 cells were fixed in formalin and viral load wasmeasured byGFP fluorescence on aGE Typhoon (526 sp filter, 488 nm excitation).
The signal was quantified in NIH ImageJ and graphed.
(D) A graph of the survival of IFNAR1/ MEFs 24 hr after infection with HRV-16 produced from a primary infection of A549 cells as per (C). MEFs were rinsed,
fixed, and stained with crystal violet and surviving cells were quantitated by measuring absorbance (OD595nm).
(E) A quantitation of virus uptake, measured as GFP fluorescence intensity, for cells expressing WT, catalytically inactive (K271R) PKR, or PKR-deficient (null)
MEFs infected with eGFP-HSV-1 as per (B). The phenotype of the cells is shown in Figure S5F.
Imaris was used to demarcate the cell boundary and quantitate the internalized fluorescent signal. The experiment was performedmultiple times, in triplicate, with
one indicative experiment being displayed. Error is displayed as mean ± SEM.
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(Figure 6A). Synonymous with this, immunocytochemical stain-
ing for the b-galactosidase enzyme directly, or detection of the
blue DiX-Indigo precipitate produced by b-galactosidase
conversion of X-gal, was markedly decreased with reduced
GSN levels (Figures 6B and 6C). These data indicate a significant802 Immunity 36, 795–806, May 25, 2012 ª2012 Elsevier Inc.functional role for the regulation of GSN in restricting virus infec-
tion, both in vitro and in vivo.
These results provide a context for the advantage of innate
immune regulation of the actin-modifying protein GSN, by which
the control of GSN by PKR constitutes a mechanical antiviral
mechanism.
Figure 6. GSN Affects Virus Infection of Murine Lung
(A) GSN levels in cells surrounding the alveoli from mice treated with lentivirus expressing control nontargeting (shCONT) or GSN-targeting (shGSN) shRNAs is
graphed at the bottom of the figure, with representative images above. GSN was detected (green) by immunocytochemistry.
(B) A quantitation of the uptake of recombinant adenovirus, asmeasured by immunocytochemistry of b-galactosidase (b-gal) (red) in alveoli frommice treatedwith
either the control or GSN-targeting shRNAs.
Nuclei are stained with Hoechst 3342 (blue) in (A) and (B).
(C) An alternative quantitation of adenovirus infection inwhich b-galactosidase activity ismeasured through the conversion of the colorless X-gal by the enzyme to
the blue precipitate (DiX-indigo). The number of blue pixels per image from whole lung sections was calculated with the Metamorph software. The images above
the graph are RGB merged trans-illumination light images.
A minimum of 30 images was collected from each of five mice for each group for the analysis. Error is displayed as mean ± SEM.
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Here we describe an interaction between the actin-binding
protein GSN and the protein kinase PKR. This protein interaction
is demonstrated to have fundamental biological consequence by
regulating the cell cytoskeleton and dependent processes. We
show, by both in vitro assay with recombinant proteins and by
assessing endogenous function in cells, that PKR inhibits GSN
activity. This inhibition occurred with either WT or the kinase-
dead PKR mutant (K296R), indicating a kinase-independent
function for PKR. At homeostasis, GSN forms a spatial arrange-
ment in which the actin-binding domains are inaccessible. Acti-
vation of GSN instigates a conformational change to expose its
actin-binding domain. Regulation of GSN has been previously
shown to occur through activation from calcium influx or inhibi-
tion by PtdIns(4,5)P2 binding, triggering consequent phosphory-
lation by protein kinase Cs (PKCs) or pp60c-src. In the absence of
detected phosphorylation control by PKR, we propose a unique
mechanism whereby PKR affects the cellular cytoskeleton bybinding to GSN and sequestering the protein in an inactive
conformation away from actin. Accordingly, a truncated GSN
with reduced autoinhibition interacted less with PKR. Juxta-
posed to this, analysis of direct protein associations demon-
strated that increased levels of PKR reduce the association of
GSN with actin.
As an expected consequence of the control of GSN by PKR,
a number of actin-dependent functions were altered in cells
ablated for PKR. This was evident by PKR-deficient fibroblasts
having decreased amounts of filamentous actin and reduced
rates of actin polymerization compared to WT cells. A reduction
in actin stress fibers in PKR-deficient cells is a good indicator of
altered lamellipodia and filopodia function and so can be attrib-
uted to elevated GSN activity (Hoffmeister et al., 2001; Mazur
et al., 2010). Importantly, the altered actin state in PKR-deficient
fibroblasts could be rescued by restoring PKR expression or by
siRNA knockdown of GSN and these effects in PKR-deficient
fibroblasts are antithetical to those in GSN-deficient fibroblasts
(Witke et al., 1995). This PKR-dependent control of the actinImmunity 36, 795–806, May 25, 2012 ª2012 Elsevier Inc. 803
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tion of GSN by PKR, ablating PKR in fibroblasts markedly
elevated membrane ruffling. In accordance with increased
membrane ruffling, PKR-deficient fibroblasts showed increased
uptake of dextran sulfate. Together, the data suggest that the
inhibition of GSN by PKR could bolster the immune response
by limiting pathogen entry into uninfected cells. This scenario
was persuasively supported by the demonstration that reduced
expression of GSN also reduced entry and production of both
herpes virus and rhinovirus in cells.
Hence, our findings suggest a role for GSN in the suscepti-
bility of cells to infection. Viruses and bacteria have been
shown to alter the cytoskeleton through regulation of actin-
binding proteins, demonstrating the importance of the cellular
cytoskeleton during infection (Doceul et al., 2010; McGhie
et al., 2004). Previously, GSN was shown to be required for
the transport and release of Parvovirus from infected cells
(Ba¨r et al., 2008). As stated, reduction of GSN suppressed virus
entry into the cell and accordingly reduced virus production
and virus-induced cellular death, supporting the concept that
GSN is an antiviral target. GSN-regulated processes could
also be predicted to be important in formation of the immune
synapse, and so PKR could potentially affect processes such
as antigen presentation. Potentially relevant to this, PKR-defi-
cient mice have been demonstrated to have delayed develop-
ment of virus-specific T cells and diminished protective immu-
nity (Nakayama et al., 2010). Unlike cells of the immune system,
fibroblasts and some epithelial cells have a high dependency
on GSN for regulation of actin during these processes. These
effects on the cell suggest that the benefit of the control of
GSN by PKR may be in the immune response to intracellular
pathogens. It would, therefore, be interesting to measure the
effect of PKR on actin remodeling in other cell types, particu-
larly dendritic and T cells.
Unlike GSN, PKR has a well-established role in innate immu-
nity, particularly in protection against viral infection. However,
the kinase has not previously been linked to control of the cell
cytoskeleton. Other reports have proposed that the innate
immune proteins RIG-I and Bcl2 modify the cell cytoskeleton
(Ke et al., 2010; Mukherjee et al., 2009). In these instances the
proteins directly bind to actin filaments. Although we also found
PKR bound to actin, this association did not alter with stimuli that
activated PKR and so does not account for the activation-
dependent effects of PKR upon actin. Instead, we propose
that PKR-dependent modulation of the cytoskeleton appears
to be via direct control over the actin-regulatory protein GSN.
PKR expression is induced by type I IFNs produced in response
to viral infection. Accordingly, we showed that treatment of fibro-
blasts with IFN-a increased the formation of actin filaments.
Importantly, this effect was significant only in WT and not in
PKR-deficient fibroblasts. Hence, IFN-mediated effects upon
the state of actin in fibroblasts were largely attributable to
PKR. This is informative in light of the previously noted RIG-I-
dependent effects on the actin cytoskeleton. Therefore, part of
the systemic resistance to virus infection induced by IFNs may
be attributable to the control of GSN by PKR in uninfected cells.
Crucially, we also show that the association between PKR and
GSN was disrupted upon activation of PKR and this disruption
was ablated in kinase-dead PKR (K296R). Hence, PKR can act804 Immunity 36, 795–806, May 25, 2012 ª2012 Elsevier Inc.as a switch to control GSN, with inhibition of GSN released
upon activation of PKR by virus replication.
In summary, PKR associates with GSN to inhibit its activity.
This effect occurs at homeostatic condition and is reinforced
by IFN (which induces PKR) but is lost upon activation of PKR.
As a consequence of this, PKR was shown to alter actin
dynamics and accordingly the cell cytoskeleton and dependent
processes. Together our data suggest that PKR could bolster
resistance to pathogens by altering mechanical features of the
cell that limit viral infection. This concept, that innate immunity
can regulate actin filament formation, actin-dependent
processes in cells, and feed back to innate immunity through
membrane ruffling, endocytosis, and viral uptake, is an important
advance in our understanding of cell immunity and may have
significant implications for the interplay between different cell
types that subsequently influence the development of acquired
immune resistance. An additional implication of our findings is
that the cell cytoskeleton might be targeted as a method of
achieving broad antiviral protection.
EXPERIMENTAL PROCEDURES
Cell Treatments
Cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum (FBS) at 37C in a 5% CO2 humidified
incubator and plated onto either confocal glass coverslips or Fluorodishes
(WPI Inc.) for imaging. Prior to visualization of actin filaments, serum
(0.05%–1%) was reduced overnight and then removed entirely immediately
prior to FRAP experiments. MEFs, HeLa, A549, or HEK293T cells at approxi-
mately 40%–60% confluency were transfected with plasmid constructs with
Fugene HD/6 (Roche) according to the manufacturer’s instructions. Either
100 ng DNA per 12 mm round coverslip in a 24-well plate (BD Falcon) or
200 ng for a 35 mm Fluorodish was transfected. The Venus constructs were
transfected in equimolar ratios into cells on glass coverslips. A minimum of
16 hr was given for maturation of a fluorescent signal.
Viral infections were conducted at a multiplicity of infection of between 10
and 100 for either human HSV-1 or HRV-16 in full or 2% serum, respectively.
Cells were rinsed with PBS and then fixed in 10% formalin, rinsed again, then
permeabilized in 0.1% Triton X-100 in PBS for 5 min. HRV-16 entry into cells
was quantitated with the monoclonal antibody against VP2 capsid protein,
RV16-7, incubated for 1 hr, followed by the secondary antibody. Virus-infected
cells were prelabeled with Celltracker CMRA or Alexa 647 Phalloidin to detect
the cell boundary. Viral production was measured 24 hr after infection by
titrating the culture supernatant onto L929 cells.
Uptake of dextran particles was visualized in immortalized fibroblast cells al-
lowed to attach overnight prior to reducing the serum levels (1%). Cells were
stained with the plasma membrane stain CellMask, according to the manufac-
turer’s protocol, prior to the addition of FITC-labeled 3 kDa dextran particles at
a concentration of 25 mg/ml. Cells were fixed after 45 min and imaged as
described.
Additional details about the experimental reagents are described in the
Supplemental Information.
Fluorescence Microscopy
F- and G-actin was visualized by staining for 30 min with Alexa 488 phalloidin
and TRITC-deoxyribonuclease-I according to the manufacturer’s guidelines.
The F:G-actin ratio wasmeasured in 96-well format on theCellomics VTi Array-
Scan high content screener with the green fluorescein (FITC, 475 ± 40 nm) and
red (TRITC, 549 ± 9 nm) channels. Cellular F-actin was visualized by fixing,
staining, and mounting on coverslips in Mowiol 4-88 and imaging with the
Nikon C1 with GFP (excitation [Ex] 487 nm, emission [Em] 500–530 nm) and
TRITC (Ex 547 nm, Em 567–642 nm) channels, as well as on the Applied Preci-
sion Deltavision Core System microscope (Semrock, GFP filter set). Particle
engulfment or virus infections were similarly imaged as single confocal plane
images on the Zeiss LSM 780 by overlapping tile-scanning with a minimum
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on the Deltavision Core system. Cells were modeled for the cell edge in Imaris
to ensure that the fluorescent signal was internal. All Deltavision images under-
went at least 15 rounds of deconvolution with the Deltavision algorithm.
Actin filaments were quantified after staining with phalloidin, as described
previously (Yoshigi et al., 2003). Deconvoluted Deltavision images were pro-
cessed in the Bitplane Imaris software. Built-in surface rendering was used
to model actin stress fibers/cell, using the software to exclude actin filaments
smaller than 1 mm in width and 2–5 mm in length. The edge of the cell was
excluded from calculations. Statistics for average filament length (ellipsoid
length), average number of filaments (objects), and total filament volume
(sum volume) were exported from the modeled actin stress fiber surfaces. A
total of 12 images per cell type (four per coverslip, in triplicate) were modeled
and statistics exported.
FRET and FRAP measurements were performed on the Leica SP5 multi-
channel confocal with a bleach Ex of 40%–50% of a 20 mW laser at 458
(CFP), 514 (Venus), and 561 (RFP) nm to obtain 50% bleaching. To visualize
actin filaments (live cell or recombinant actin), the SP5 was run at 200 mHz,
enhanced mode, and 12/16 bit images were taken. FRAP was performed on
cells transfected with mRFP1-actin and grown in reduced serum overnight to
enhance actin stress fiber formation. Regions of approximately 3 mm were
selected on large actin stress fibers. Measurements of fluorescence intensity
were then recorded every 2.5628 s for 120 s. Low laser intensity was used for
continual measurements to minimize bleaching. Measurements were then
normalized to the maximum and minimum intensity (post-bleach point). Data
were then accumulated from multiple experiments with multiple regions of
interest and up to 50 cells per cell line. FRAP curves were analyzed as per
the EMBL FRAPmanual (Koti Miura). Individual one-phase exponential associ-
ation curves were also plotted in Graphpad Prism software and the t1/2 times of
curveswith anR2 value of greater than 0.25 and anSDof <5were recorded. The
majority of PKR-deficient and Bac10 cells did not reach significant recovery
after bleaching tomodel regression curves. Theminimum number of filaments,
after thresholds, per time point for any cell type was 18, with a maximum of 65.
Acceptor photobleaching FRET was performed between GSN-CFP or
GSNCT-CFP and PKR-Venus, or actin-mRFP1/actin-eYFP. Photobleaching
was optimized to reduce the fluorescent signal after bleaching to approxi-
mately 50% of the original intensity. FRET efficiencies were calculated with
the inbuilt software (Leica LAS Advanced Fluorescence). Images were
acquired sequentially with averaging, and donor/acceptor-only controls
were utilized to ensure no spectral overlap. FLIM experiments were conducted
with a lifetime imaging attachment (Lambert Instruments) mounted on an in-
verted microscope (TE2000U, Nikon Inc, Japan), as described previously
(Clayton et al., 2005). Fixed cells were excited with epi-illumination with
a modulated 455 nm LED at 40 MHz and observed with a 1003 NA 1.25 oil
objective (Nikon Plan-Fluor) through a filter set designed for CFP (Nikon,
EX430-450, DM455, BA465-495) or FITC (Nikon FITC, DM505, Em 515–
555 nm). The mean extent of lifetime quenching was estimated from the
mean fluorescence lifetime (mean of the phase and modulation lifetimes) of
the cells in the absence or presence of an acceptor. Average lifetime from
>25 single cells is plotted on an AB plot, as described previously (Clayton
et al., 2004), to demonstrate lifetime shortening of FRET in the presence of
acceptor. CFP/GFP controls were used to ensure that the lifetime of fusion
proteins resembled that of individual fluorophores.
Split Venus experiments were imaged on the Leica SP5 multichannel under
eYFP conditions and on a Nikon C1 confocal (GFP settings).
Actin polymerization assays were performed with rhodamine-labeled actin
monomers prepared at 5 mM and incubated with or without 0.5 mM GSN1-6,
GSN3-4, PKR, and K296R-PKR in polymerization buffer and used as previ-
ously published (Yin et al., 1980, 1981). The reaction was mixed and spotted
onto 12mmcoverslips for 90min at room temperature prior tomounting inMo-
wiol 4-88. Actin polymers were visualized by the tile-scanning module within
the Leica LAS AF software and collecting continuous images in a 3 3 5 grid.
Images were quantified in NIH Image J by mean fluorescence intensity of
the entire field of view.
In Vivo Experiments
Intranasal inhalationwas used to deliver recombinant lentivirus and adenovirus
into the lung of 6- to 12-week-old C57BL6/J mice according to a previouslypublished protocol (DuPage et al., 2009). Lentiviruses containing control
(SHC001) or GSN-targeting (SHCLNG-NM_146120) shRNAs were generated
according to the manufacturer’s instructions (Sigma) and infected at 1 3 105
MOI for 3 days to reduce levels of GSN in the mouse airway epithelia. Subse-
quent infection with an MOI of 5 3 106 Adeno-b-Gal-GFP (Gene Transfer
Vector Core) was used to identify differences in viral uptake into the lung. After
4–5 days, lungs were removed and processed (according to DuPage et al.,
2009). GSN was quantitated by immunostaining with the N-18 (Santa Cruz)
primary and Alexa 647 secondary antibodies. b-gal was detected by immunos-
taining with the ZBG1 (Zymed) primary and Dylight 594 (AbCam) secondary
antibodies, as well as by color conversion of X-gal. RGB merged images
were collected under transmitted light and immunostaining collected under
fluorescence imaging on the Deltavision (with predominantly Far-Red/Cy5
filters to minimize autofluorescence). All mice used in experiments were
treated according to practices approved by the Monash University Animal
Ethics Committee as obligated by the Australian Code of Practice for the
Care and Use of Animals for Scientific Purposes, in compliance with standards
mandated by the National Health and Medical Research Council and National
Institutes of Health.
Statistics
Unless otherwise stated, all statistics were performed with the GraphPad
Prism software and displayed as the mean and SEM. If not otherwise stated
in the figure legends, all significance analyses were two-tailed, unpaired,
Student t tests comparing two sets of data. *p < 0.05; **0.05 R p R 0.001;
***p < 0.001; ns, not significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and four movies and can be found with this article online at
doi:10.1016/j.immuni.2012.02.020.
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